Joint Corp (JYNT) Stock Price & Analysis
Joint Corp (JYNT) rose 2.56% to USD 8.41 as of June 10, 2026 at 07:00 UTC, according to Nexqual real-time market data.
JYNT last closed at USD 8.2; the session ranged USD 8.16–8.49 on volume of 129,729 shares. Market capitalization is $119.89M, with a 52-week range of USD 7.5–13 (NCM). Source: Nexqual, June 10, 2026 at 07:00 UTC.
Key Statistics (as of June 10, 2026 at 07:00 UTC)
| Price | USD 8.41 |
|---|---|
| Change | ▲ 2.56% (up) |
| Previous Close | USD 8.2 |
| Open | USD 8.2 |
| Day Range | USD 8.16 – 8.49 |
| 52-Week Range | USD 7.5 – 13 |
| Volume | 129,729 shares |
| Market Cap | $119.89M |
| Exchange | NCM |
Technical Analysis (JYNT)
Nexqual's technical model rates JYNT "SELL" based on 1 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 07:00 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 39.13 (neutral) |
| vs SMA50 | Below (USD 8.75) |
| MACD | -0.11 (negative) |
Analyst Ratings (JYNT)
Wall Street analysts rate JYNT "None" based on 3 analysts, with a mean price target of USD 10 (range USD 9–12), per Nexqual as of June 10, 2026 at 07:00 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 10 |
| High Target | USD 12 |
| Low Target | USD 9 |
| Buy / Hold / Sell | 1 / 3 / 0 |
Earnings (JYNT)
| Next Earnings Date | 2026-08-06 |
|---|---|
| EPS Estimate | USD 0.07 |
| Revenue Estimate | $14.57M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.08 vs est 0.03 ▲ beat |
| 2025-12-31 | USD 0.06 vs est 0.04 ▲ beat |
| 2025-09-30 | USD 0.13 vs est 0 ▲ beat |
| 2025-06-30 | USD -0.06 vs est -0.02 ▼ miss |
Source: Nexqual, June 10, 2026 at 07:00 UTC.
Financials & Fundamentals (JYNT)
| Total Revenue | $56.64M |
|---|---|
| Revenue Growth (YoY) | +13.30% |
| Gross Margin | +80.62% |
| Operating Margin | +6.07% |
| Profit Margin | +5.72% |
| ROE | +7.00% |
| Debt / Equity | 13.18 |
| Current Ratio | 1.64 |
| Total Cash | $20.68M |
| Total Debt | $2.04M |
| Free Cash Flow | $9.30M |
Source: Nexqual, June 10, 2026 at 07:00 UTC.
Financial Health Score (JYNT)
Nexqual rates Joint Corp's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 07:00 UTC.
| Growth | Critical — Revenue -55% YoY (annual), sharp decline |
|---|---|
| Profitability | Strong — Gross margin 81%, operating 6% |
| Balance Sheet | Strong — $21M cash vs $2M debt, net cash position |
| Cash Flow | Strong — FCF $9M, 17% margin |
| Efficiency | Mixed — ROE 7%, ROA 0.6% |
Ownership (JYNT)
| Insider Ownership | +16.11% |
|---|---|
| Institutional Ownership | +74.20% |
| Shares Outstanding | 14.26M |
| Float | 6.62M |
| Short % of Float | +17.12% |
Source: Nexqual, June 10, 2026 at 07:00 UTC.
Leadership (JYNT)
Joint Corp is led by Sanjiv Razdan (age 55), CEO, President & Director, per Nexqual as of June 10, 2026 at 07:00 UTC.
| CEO, President & Director | Sanjiv Razdan (age 55) |
|---|---|
| Chief Financial Officer | Scott Justin Bowman (age 58) |
| Senior Vice President of Operations & Patient Experience | Ron Stilwell |
| Chief Technology Officer | Charles Nelles |
| Vice President of Chiropractic & Compliance | Steven Knauf |
Major Backers & Investors (JYNT)
Notable institutional backers of Joint Corp include Bandera Partners LLC, Skylands Capital, LLC, JCP Investment Management, LLC, according to Nexqual as of June 10, 2026 at 07:00 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Bandera Partners LLC | 27.62% |
| Skylands Capital, LLC | 6.27% |
| JCP Investment Management, LLC | 4.17% |
| First Foundation Advisors | 2.37% |
| Russell Investments Group, Ltd. | 2.26% |
| ADVISORS' INNER CIRCLE III-First Foundation Total Return Fund | 2.14% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 11.32% |
| BlackRock | 7.65% |
| Geode Capital | 2.02% |
| State Street | 2% |
Source: Nexqual, June 10, 2026 at 07:00 UTC.
From Joint Corp's Latest SEC 10-K Filing (filed 2026-03-13)
Key Strengths & Strategy (as disclosed to the SEC)
- The chiropractors who work in our system are subject to ethical guidelines and operating standards of professional and trade associations and private accreditation agencies.
Partnerships
- In the event of a finding of joint employer status under the NLRA, a franchisor would be required to collectively bargain or otherwise deal with a union that does not represent the franchisor's own employees, lose the protections against union picketing of neutral employers in the event of a labor disagreement between a franchisee and a franchisee's employees, and share in liability for labor and employment violations committed by a franchisee.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IRMD | iRadimed Corporation | USD 96.42 | ▲ 3.6% |
| OPRX | OptimizeRx Corporation | USD 5.07 | ▼ 0.78% |
| KIDS | OrthoPediatrics Corp. | USD 18.49 | ▲ 0.93% |
| CLAR | Clarus Corporation | USD 2.92 | ▲ 1.74% |
| XPEL | XPEL, Inc. | USD 45.83 | ▲ 2.85% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:00 UTC. This page is informational and not investment advice.